CONTACT

Prokarium to attend the 2023 BIO CEO & Investor Conference in New York, February 6-9, 2023

Kristen Albright, Prokarium’s CEO, will be attending the BIO CEO & Investor Conference in New York February 6-9, 2023

Related News

Prokarium appoints Ibs Mahmood as Chief Executive Officer

London, UK – November 11, 2025 – Prokarium, a clinical-stage biopharmaceutical company pioneering the field of microbial immunotherapy, today announced  the...
Read more

Prokarium expands IP portfolio with two new U.S. patents strengthening its position in bladder cancer

LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...
Read more

Prokarium expands IP portfolio with two new U.S. patents strengthening its position in bladder cancer

LONDON, United Kingdom, November 1, 2024 – Prokarium, a biopharmaceutical company developing innovative cancer treatments, today announced the...
Read more

Prokarium Secures UKRI Grant to Fund Development of Living Cures Platform

LONDON, UK, March 14, 2024 – Prokarium announces they have been awarded a UK Research and Innovation (UKRI) Engineering Biology...
Read more

Prokarium Secures UKRI Grant to Fund Development of Living Cures Platform

LONDON, UK, March 14, 2024 – Prokarium announces they have been awarded a UK Research and Innovation (UKRI) Engineering Biology...
Read more
Icons
CONTACT